1. Home
  2. PNTG vs RVPHW Comparison

PNTG vs RVPHW Comparison

Compare PNTG & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • RVPHW
  • Stock Information
  • Founded
  • PNTG 2019
  • RVPHW N/A
  • Country
  • PNTG United States
  • RVPHW United States
  • Employees
  • PNTG N/A
  • RVPHW 15
  • Industry
  • PNTG Medical/Nursing Services
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNTG Health Care
  • RVPHW Health Care
  • Exchange
  • PNTG Nasdaq
  • RVPHW Nasdaq
  • Market Cap
  • PNTG 1.1B
  • RVPHW N/A
  • IPO Year
  • PNTG N/A
  • RVPHW 2018
  • Fundamental
  • Price
  • PNTG $32.00
  • RVPHW $0.08
  • Analyst Decision
  • PNTG Buy
  • RVPHW
  • Analyst Count
  • PNTG 4
  • RVPHW 0
  • Target Price
  • PNTG $37.50
  • RVPHW N/A
  • AVG Volume (30 Days)
  • PNTG 219.3K
  • RVPHW N/A
  • Earning Date
  • PNTG 11-06-2024
  • RVPHW N/A
  • Dividend Yield
  • PNTG N/A
  • RVPHW N/A
  • EPS Growth
  • PNTG 62.20
  • RVPHW N/A
  • EPS
  • PNTG 0.68
  • RVPHW N/A
  • Revenue
  • PNTG $652,302,000.00
  • RVPHW N/A
  • Revenue This Year
  • PNTG $27.15
  • RVPHW N/A
  • Revenue Next Year
  • PNTG $16.03
  • RVPHW N/A
  • P/E Ratio
  • PNTG $47.02
  • RVPHW N/A
  • Revenue Growth
  • PNTG 24.58
  • RVPHW N/A
  • 52 Week Low
  • PNTG $11.95
  • RVPHW N/A
  • 52 Week High
  • PNTG $37.13
  • RVPHW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 43.51
  • RVPHW N/A
  • Support Level
  • PNTG $31.45
  • RVPHW N/A
  • Resistance Level
  • PNTG $34.36
  • RVPHW N/A
  • Average True Range (ATR)
  • PNTG 1.41
  • RVPHW 0.00
  • MACD
  • PNTG -0.17
  • RVPHW 0.00
  • Stochastic Oscillator
  • PNTG 53.16
  • RVPHW 0.00

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: